Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

New Board Member For Jounce Therapeutics

Executive Summary

Cancer immunotherapy company Jounce Therapeutics Inc. has appointed Barbara G. Duncan to its board of directors. Duncan has spent the last seven years at Intercept Pharmaceuticals Inc., where she was chief financial officer and treasurer. Prior to this, she held a number of leadership roles at DOV Pharmaceutical Inc., including chief executive officer. Duncan currently also serves on the boards of Edgemont Pharmaceuticals, LLC., Medgenics Inc. and Adaptimmune.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

SC065340

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel